Clinical trial
1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)
NCT00662740 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 15, 2008
- Completion date
- November 21, 2008
- Enrollment
- 220 (actual)
- Sites
- 72
Conditions
As the registry lists them; a condition with its own page is linked.